https://www.selleckchem.com/products/mbx-8025.html
The incidence of AKI was also significantly lower with IOCM in younger patients, without diabetes, anemia, coronary artery disease history, CKD, chronic or persistent atrial fibrillation, left ventricular ejection fraction ≤35%, and in patients with low operative mortality risk scores, receiving lower amounts of dye (p0.05 for all). Importantly, multivariate analysis identified LOCM administration as an independent risk factor for both AKI (p=0.006) and 1-year mortality (p=0.001). The use of IOCM have a favorable impact on renal fu
Like
Comment
Share
